Connection

DAVID G JOHNSON to Signal Transduction

This is a "connection" page, showing publications DAVID G JOHNSON has written about Signal Transduction.
Connection Strength

0.136
  1. Viral inhibition of MHC class II antigen presentation. Trends Immunol. 2003 May; 24(5):278-85.
    View in: PubMed
    Score: 0.063
  2. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway. Oncogene. 2006 Feb 09; 25(6):867-76.
    View in: PubMed
    Score: 0.019
  3. Inhibition of TCR signaling by herpes simplex virus. J Immunol. 2006 Feb 01; 176(3):1825-33.
    View in: PubMed
    Score: 0.019
  4. The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitation. Oncogene. 2019 04; 38(17):3216-3231.
    View in: PubMed
    Score: 0.012
  5. The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells. Haematologica. 2015 Mar; 100(3):e110-3.
    View in: PubMed
    Score: 0.009
  6. Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma. Blood. 2012 Aug 02; 120(5):1077-86.
    View in: PubMed
    Score: 0.007
  7. A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development. Cancer Cell. 2010 Sep 14; 18(3):220-30.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.